REFERENCES
- Farmer S., Anderson P., Burns P., Velagaleti R. Forced degradation of ibuprofen in bulk drug and tablets. Pharm. Tech. 2002; 26: 28–42
- Felton L. A., Timmins G. S. A nondestructive technique to determine the rate of oxygen permeation into solid dosage forms. Pharm. Dev. Technol. 2006; 11: 1–7
- Hartauer K. J., Arbuthnot G. N., Baertschi S. W., Johnson R. A., Luke W. D., Pearson N. G., Rickard E. C., Tingle C. A., Tsang P. K. S., Wiens R. E. Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: Identification and control of an oxidative degradation product. Pharm. Dev. Technol. 2000; 5: 303–310
- Hong J., Lee E., Carter J. C., Masse J. A., Oksanen D.A. Antioxidant-accelerated oxidative degradation: A case study of transition metal ion catalyzed oxidation in formulation. Pharm. Dev. Technol. 2004; 9: 171–179
- Hovorka S. W., Schoneich C. Oxidative degradation of pharmaceuticals: Theory, mechanisms and inhibition. J. Pharm. Sci. 2001; 90: 253–269
- Khossravi M., Borchardt R. T. Chemical pathways of peptide degradation: IX. Metal-catalyzed oxidation of histidine in model peptides. Pharm. Res. 1998; 15: 1096–1102
- Kumar V., Sunder N., Potdar A. Critical factors in developing pharmaceutical formulations - An overview, part II. Pharm. Tech. April, 1992; 86–92
- List P. H., Kassis G. On the permeability of various tablet coatings to water vapour and oxygen. Acta Pharm. Technol. 1982; 28: 21–33
- Monkhouse D. C. Stability aspects of preformulation and formulation of solid pharmaceuticals. Drug Dev. Ind. Pharm. 1984; 10: 1373–1412
- Nash R. A. The oxidation potentials of antioxidants in drug stabilization. Amer. Jour. Pharm. 1958; 138: 152–164
- Obara S., Maruyama N., Nishiyama Y., Kokubo H. Dry coating: An innovative enteric coating method using a cellulose derivative. Eur. J. Pharm. Biopharm. 1999; 47: 51–59
- Packer J. E., Slater T. F., Willson R. L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979; 278: 737–738
- Phease T. L., Billingham N. C., Bigger S. W. The effect of carbon black on the oxidative induction time of medium-density polyethylene. Polymer 2000; 41: 9123–9130
- Rosa D. S., Sarti J., Mei L. H. I., Filho M. M., Silveira S. A study of parameters interfering in oxidative induction time (OIT) results obtained by differential scanning calorimetry in polyolefin. Polymer Testing 2000; 19: 523–531
- Rowe R. C., Sheskey P. J., Owen S. Handbook of Pharmaceutical Excipients. Pharmaceutical Press, London 2006
- Skiba M., Skiba-Lahiani M., Marchais H., Duclos R., Arnaud P. Stability assessment of ketoconazole in aqueous formulations. Int. J. Pharm. 2000; 198: 1–6
- Szymula M. Atmospheric oxidation of B-carotene in aqueous, pentanol, SDS microemulsion systems in the presence and absence of vitamin C. J. Disper. Sci. Tech. 2004; 25: 129–137
- Tan C. P., Che Man Y. B, Selamat J., Yusoff M. S. A. Comparative studies of oxidative stability of edible oils by differential scanning calorimetry and oxidative stability index methods. Food Chem. 2002; 76: 385–389
- Templeton A. C., Han Y.- H. R., Mahajan R., Chern R. T., Reed R. A. Rapid headspace oxygen analysis for pharmaceutical packaging applications. Pharm. Tech. 2002; 26: 44–61
- Townsend M. W., Byron P. R., DeLuca P. P. The effects of formulation additives on the degradation of freeze-dried ribonuclease A. Pharm. Res. 1990; 17: 1086–1091
- Waterman K. C., Adami R. C. Accelerated aging: Prediction of chemical stability of pharmaceuticals. Int. J. Pharm. 2005; 293: 101–125
- Waterman K. C., Adami R. C., Alsante K. M., Hong J., Landis M. S., Lombardo F., Roberts C. J. Stabilization of pharmaceuticals to oxidative degradation. Pharm. Dev. Technol. 2002; 7: 1–32
- Waterman K. C., Roy M. C. Use of oxygen scavengers to stabilize solid pharmaceutical dosage forms: a case study. Pharm. Dev. Technol. 2002; 7: 227–234